Canada: English
Australia Canada (English) Japan New Zealand Saudi Arabia United Kingdom United States
Audience: General Cardiologist
General Cardiologist Heart Team Member
HeartValves - Canada toggle menu
General Cardiologist
General Cardiologist Heart Team Member
Patients Trust You to Identify sAS
Timely Intervention is Critical
Diagnosis Challenges
Detecting Hidden Symptoms
ACC/AHA Guideline Updates
ESC/EACTS VHD Guideline Updates
CCS Position Statement
Guide Patients to the Best Outcomes
Less Invasive, Lowest-Risk Procedure
Patient Benefits
Real-World TAVI Experience
The Low-Risk Patient
Collaborate With a Heart Team
Benefits of a Multidisciplinary Evaluation
Resource Library
Register for Updates
Events / Conferences
Canada: English
Australia Canada (English) Japan New Zealand Saudi Arabia United Kingdom United States
HeartValves - Canada
Patients Trust You
to Identify sAS
Timely Intervention is Critical Diagnosis Challenges Detecting Hidden Symptoms ACC/AHA Guideline Updates ESC/EACTS VHD Guideline Updates CCS Position Statement
Guide Patients to
the Best Outcomes
Less Invasive,
Lowest-Risk Procedure
Patient Benefits Real-World TAVI Experience The Low-Risk Patient
Collaborate With
a Heart Team
Benefits of a
Multidisciplinary
Evaluation
Resource Library
Register for Updates
Events/Conferences

ESC/EACTS VHD Guideline
2021 Updates

ESC/EACTS VHD Guideline
2021 Updates

  1. Home
  2. Referring Cardiologist
  3. Patients Trust You to Identify sAS
  4. ESC/EACTS VHD Guideline Updates
  5. VHD Registration

Thank you!

Thank you for ordering a copy of the ESC/EACTS Pocket Guidelines.

If you ticked the box for email communications, you will now receive emails on the latest developments and industry insights on heart valve innovation and technology

Back to 2021 ESC/EACTS VHD Guidelines
HeartValves - Canada
Legal Terms
Privacy Policy
Site Map
Cookie Preferences
Medtech Canada

The Medical Technology Association of Canada (“Medtech Canada”) is dedicated to advancing healthcare through innovative technologies, devices and diagnostics (“technologies”). Medtech Canada believes that access to high quality, cost-effective healthcare technology is paramount to the improvement of patient care. Medtech Canada represents companies that design, develop, manufacture and market medical technologies and related services used in the treatment, mitigation, diagnosis or prevention of a disease or abnormal physical condition.

The Medtech Canada Code of Conduct is designed to ensure that all relationships between Companies and Healthcare Professionals are governed by the highest ethical standards. By adhering to these carefully developed guidelines, Companies create a win-win situation. Their vital relationships with Healthcare Professionals are safeguarded, legitimate business practices are affirmed and patients across Canada benefit from vital and innovative collaboration between Healthcare Professionals and the medical technology industry.

For a copy of the Medtech Canada Code of Conduct visit: www.medtechcanada.org/page/code

Edwards, Edwards Lifesciences, the stylized E logo, Edwards Commander, Edwards SAPIEN, Edwards SAPIEN XT, Edwards SAPIEN 3, Edwards SAPIEN 3 Ultra, PARTNER, PARTNER 3, SAPIEN, SAPIEN XT, SAPIEN 3, and SAPIEN 3 Ultra are trademarks or service marks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

©2025 Edwards Lifesciences Corporation. All rights reserved. PP-CAN-5875 Rev1.0

Edwards Lifesciences • 1919 Minnesota Ct #501, Mississauga, ON L5N 1P8 CANADA • edwards.com

Are you a healthcare professional?

Content relating to HeartValves.com is intended for healthcare professionals.

No, go to patient site
Yes, continue

You are about to leave HeartValves.com

Click "Continue" to proceed or "Return" to return to HeartValves.com

Return
Continue